Glucotrack, Inc.

NASDAQ:GCTK
Annual Meeting

of Shareholders

MEETING DATE

08/18/2026
DEF 14A FILED
07/17/2026
PUBLISHED
07/17/2026 8:45 pm
TIME TO PUBLISH
07/19/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:GCTK · CUSIP 45824Q101 · CIK 0001506983

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

4
FOR
1
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of six directors
board
Elevated
For
Board FOR · Duopoly unknown No divergence flagged

Board nominated six existing directors for election at the annual meeting.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Advisory vote on executive compensation (Say-on Pay)
compensation
Elevated
For
Board FOR · Duopoly unknown No divergence flagged

Compensation committee said the prior advisory vote indicated considerable stockholder support for its compensation approach.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
Ratification of the appointment of CBIZ CPAs P.C. as independent registered public accounting firm for the year ending December 31, 2026
auditor
Elevated
For
Board FOR · Duopoly unknown No divergence flagged

Audit committee selected CBIZ as independent registered public accounting firm for 2026.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Approval of one or more amendments to the certificate of incorporation to effect one or more reverse stock splits at an aggregate ratio not to exceed one-for-thirty
other
Elevated
For
Board FOR · Duopoly unknown No divergence flagged

Filing states a reverse stock split may be necessary to maintain Nasdaq Bid Price Rule compliance.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Approval of the proposed warrant inducement, including the repricing of existing warrants and issuance of inducement warrants and shares upon exercise, for purposes of complying with Nasdaq Listing Rule 5635(d)
other
Elevated
Against
Board FOR · Duopoly unknown ⚠ Divergence flagged

Filing states the transaction could significantly dilute current stockholders through issuance of up to 6,201,546 shares.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates